Blood Flow Restriction Training on Upper Extremity Grip Strength

October 9, 2024 updated by: Emily Rosario, Casa Colina Hospital and Centers for Healthcare

Restrict and Strengthen: Unraveling the Impact of Blood Flow Restriction Training on Upper Extremity Grip Strength

The primary objective of this prospective study is to investigate the effects of Blood Flow Restriction (BFR) training compared to traditional low-weight resistance training on grip strength in young adults.

Despite the growing interest in BFR training and its potential benefits, there is limited research specifically investigating its impact on grip strength. Understanding the effects of BFR training on grip strength could have significant implications for individuals seeking to optimize their grip performance, rehabilitation settings, and sports performance enhancement. Additionally, examining the safety and efficacy of BFR training for this specific outcome will contribute valuable insights to the scientific community.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Blood Flow Restriction (BFR) training, also known as occlusion training, is an innovative exercise technique that involves using a tourniquet or blood pressure cuff to partially restrict blood flow to the working muscles during resistance exercises. This unique approach allows individuals to achieve significant muscle strength and hypertrophy gains with lower resistance loads, making it a promising alternative to traditional high-intensity training methods. BFR training has been extensively studied in various populations, demonstrating its potential benefits for muscle growth, strength, and endurance across different muscle groups.

While much research has focused on the effects of BFR training on large muscle groups like the quadriceps and biceps, there is a paucity of studies specifically investigating its impact on upper extremity grip strength. Grip strength is a fundamental measure of hand and forearm muscle function, playing a crucial role in various activities of daily living, occupational tasks, and sports performance. Understanding the effects of BFR training on grip strength could provide valuable insights into optimizing hand and forearm strength and functional capacity.

The current study seeks to fill this research gap by examining the effects of Blood Flow Restriction (BFR) training on upper extremity grip strength in a healthy young adult population. By exploring this novel application of BFR training, we aim to contribute to the existing body of knowledge surrounding BFR's potential benefits for grip strength enhancement. The results of this study may have implications for athletes, rehabilitation programs, and individuals seeking efficient and effective ways to enhance their grip strength and overall upper extremity function.

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Pomona, California, United States, 91767
        • Recruiting
        • Casa Colina Healthcare and Hospital
        • Contact:
        • Principal Investigator:
          • Emily Rosario, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Participants must be between 18 and 35 years old at the time of enrollment.

Participants should be in good general health with no known cardiovascular, musculoskeletal, or neurological disorders that could interfere with exercise participation.

Participants must provide informed consent before enrollment in the study, indicating their willingness to participate voluntarily.

Exclusion Criteria:

  • Participants with a history of cardiovascular disease (e.g., heart disease, hypertension), musculoskeletal injuries (e.g., fractures, dislocations), or neurological disorders (e.g., neuropathy) that could affect exercise performance will be excluded.

Participants taking medications or supplements that may impact muscle strength, metabolism, or blood flow will be excluded from the study.

Pregnant individuals will be excluded due to potential risks associated with exercise and blood flow restriction during pregnancy.

Individuals with recent upper extremity injuries, such as strains, sprains, or fractures, will be excluded until fully recovered.

Blood Pressure: Participants with uncontrolled high blood pressure or other medical conditions affecting vascular health may be excluded due to potential risks associated with blood flow restriction.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Blood flow restriction with low-weight resistance training (LWRT) group
a blood flow restriction with low-weight resistance training (LWRT) group
Both groups will undergo a 6-week training intervention with training 2x a week, after which grip strength and other relevant outcomes will be measured and compared. Exercise sessions will be at least 48 hours apart. Participants will be allowed to continue with their normal exercise routine outside of the study.
No Intervention: No Blood flow restriction group which just does LWRT
a non blood flow restriction group which just does low-weight resistance training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Grip Strength
Time Frame: baseline, post-intervention (6 weeks), and follow-up (6 weeks)
Isometric grip strength will be assessed in the dominant arm after the intervention using the Jamar hydraulic hand dynamometer (Lafayette Instruments, Lafayette, IN). Participants will be positioned in sitting with the knees and hips flexed to 90 degrees and feet flat on the floor. The shoulder will be in a neutral position with the elbow flexed to 90 degrees and the forearm in neutral pronation-supination. (Crotin & Ramsey, 2021) The participant will be instructed to squeeze the dynamometer with maximal effort for 3 seconds while receiving verbal encouragement. A total of three repetitions will be completed with a 30 second rest between trials to reduce fatigue. (Crotin & Ramsey, 2021) The peak grip strength value of all three trails will be used for baseline strength and 30% of the peak value will be used to calculate the resistance (in lbs.) for the exercise protocol.
baseline, post-intervention (6 weeks), and follow-up (6 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 19, 2024

Primary Completion (Estimated)

August 1, 2025

Study Completion (Estimated)

December 1, 2025

Study Registration Dates

First Submitted

July 30, 2024

First Submitted That Met QC Criteria

July 30, 2024

First Posted (Actual)

August 2, 2024

Study Record Updates

Last Update Posted (Actual)

October 15, 2024

Last Update Submitted That Met QC Criteria

October 9, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • BFRGRIP

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Volunteers

Clinical Trials on Blood flow restriction

Subscribe